Profilo
Christina Cameron is currently Director-Investor Relations at Medicago, Inc. and Vice President-Investor Relations at Antibe Therapeutics, Inc. Former roles include Independent Director at Zero Candida Technologies, Inc. from 2024 to 2026, and Investor Relations & Media Contact at Medicenna Therapeutics Corp.
Education includes an undergraduate degree from Wilfrid Laurier University.
Posizioni attive di Christina Cameron
| Società | Posizione | Inizio |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Contatto Relazioni con gli Investitori | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Christina Cameron
| Società | Posizione | Fine |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Contatto Relazioni con gli Investitori | - |
Formazione di Christina Cameron
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Wilfrid Laurier University
Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antibe Therapeutics, Inc.
Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
















